3Johri N, Jaeger P, Robertson W, et al . Renal stone disease [J]. Medicine, 2011, 39(7) : 371 377.
4Tiselius HG. Metabolic risk evaluation and prevention of re- currence in stone disease: does it make sense [J ]9. Urolithiasis, 2016,44(1) : 91 100.
5Sharma AP, Filler G. Epidemiology of pediatric urolithiasis [J]. Indian J Urol, 2010, 26(4): 516.
6Esposito T, Rendina D, Aloia A, et al . The melatonin recep- tor 1A (MTNR1A) gene is associated with recurrent and idio- pathic calcium nephrolithiasis[J]. Nephrol Dial Transplant, 2012, 27(1): 210-218.
7Chen WC, Wu HC, Lu HF, et al . Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones[J]. Eur Urol, 2001, 39(6): 716-719.
8Xu C, Song R, "fang J, et al . Klotho gene polymorphism o~ rs3752472 is associated with the risk of urinary calculi in the population of Han nationality in Eastern China[J]. Gene, 2013, 526(2): 494-497.
9Besiroglu H, Sahin S, Otunctemur A, et al . Calcium-sensing receptor gene polymorphisms in patients with calcium urolith- iasis: a systematic review[J].Ren Fail, 2014, 36(8): 1187- 1192.
10Mittal RD, Mishra DK, Srivastava P, et al . Polymorphisms in the vitamin D receptor and the androgen receptor gene as- sociated with the risk of urolithiasis [J]. Indian J Clin Biochem, 2010, 25(2) = 119-126.
